Validated HPLC-PDA methodology utilized for simultaneous determination of Etoricoxib and Paracetamol in the presence of Paracetamol toxic impurities.

Abdel Rahman, Mona A; Elghobashy, Mohamed R; Zaazaa, Hala E; Atty, Shimaa A; El-Mosallamy, Sally S

Abdel Rahman, Mona A; Elghobashy, Mohamed R; Zaazaa, Hala E; Atty, Shimaa A; El-Mosallamy, Sally S.

Afiliación

Abdel Rahman MA; Analytical Chemistry Department, Faculty of Pharmacy, October 6 University, 6 October City, PO Box 12858, Giza, Egypt.
Elghobashy MR; Analytical Chemistry Department, Faculty of Pharmacy, October 6 University, 6 October City, PO Box 12858, Giza, Egypt.
Zaazaa HE; Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo, 11562, PO, Egypt.
Atty SA; Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Aini St, Cairo, 11562, PO, Egypt.
El-Mosallamy SS; Pharmaceutical Chemistry Department, Egyptian Drug Authority, 51 Wezaret El-Zeraa St, Cairo, Egypt.

BMC Chem ; 16(1): 108, 2022 Dec 02.

Article en En | MEDLINE | ID: mdl-36461095

Palabras clave

4-Aminophenol; Etoricoxib; HPLCPDA; Para-hydroxy acetophenone; Paracetamol; Toxic impurities

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: BMC Chem Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google